Records 1 - 5
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy.
Translational lung cancer research 2020 Dec 9 (6): 2367-2379.
Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y
| A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR-Tyrosine Kinase Inhibitors.
Cancer research and treatment : official journal of Korean Cancer Association 2016 May .
Han Ji-Youn, Lee Ki Hyeong, Kim Sang-We, Min Young Joo, Cho Eunkyung, Lee Youngjoo, Lee Soo-Hyun, Kim Hyae Young, Lee Geon Kook, Nam Byung Ho, Han Hyesun, Jung Jina, Lee Jin S
| The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Oncotarget 2016 May .
Gou Lan-Ying, Li An-Na, Yang Jin-Ji, Zhang Xu-Chao, Su Jian, Yan Hong-Hong, Xie Zhi, Lou Na-Na, Liu Si-Yang, Dong Zhong-Yi, Gao Hong-Fei, Zhou Qing, Zhong Wen-Zhao, Xu Chong-Rui, Wu Yi-Lo
| Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk.
BMC cancer 2014 14 144.
Chen Hui-Tzu, Wu Yao-Chung, Chen Shou-Tung, Tsai Hsien-Chang, Chien Yi-Ch
| Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers.
Environmental and molecular mutagenesis 2002 40 (3): 153-60.
Salama Salama A, Au William W, Hunter Glenn C, Sheahan Richard G, Badary Osama A, Abdel-Naim Ashraf B, Hamada Farid M